Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2026)
Arcturus Therapeutics Holdings' (ARCT) quarterly Other Non Operating Income came in at $35000.0 in Q1 2026, up 266.67% YoY from $9545.5 in Q1 2025, and down 95.01% on a QoQ basis from $701000.0 in Q4 2025.
Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings (ARCT) has 9 years of Other Non Operating Income data on file, last reported at $35000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 266.67% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (down 46.18% YoY) and the FY2025 annual result came in at $382000.0, down 97.49% from the prior year.
- Other Non Operating Income fell to $35000.0 in Q1 2026, from $701000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $34.0 million in Q1 2023 to a low of -$34.2 million in Q4 2023.
- A 5-year average of $456294.1 and a median of $4000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income jumped 6120.04% — and 2024, when it tumbled 5125.0%.
- Tracing ARCT's Other Non Operating Income over 5 years: stood at -$3.8 million in 2022, then plunged by 791.32% to -$34.2 million in 2023, then surged by 109.4% to $3.2 million in 2024, then tumbled by 78.19% to $701000.0 in 2025, then plunged by 95.01% to $35000.0 in 2026.
- The last three Other Non Operating Income figures came in at $35000.0 (Q1 2026), $701000.0 (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcturus Therapeutics Holdings | 233.92 Mn | 42.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -59,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Sep 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | -201,000.00 |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | -53,000.00 |
| Dec 31, 2023 | -34.18 Mn |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 149,000.00 |
| Mar 31, 2023 | 33.95 Mn |
| Dec 31, 2022 | -3.84 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | -560,000.00 |
| Mar 31, 2022 | -564,000.00 |
| Dec 31, 2021 | -2.84 Mn |
| Sep 30, 2021 | -519,000.00 |